Related Experiment Video
Updated: Jul 28, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
Fibromyalgia and Gaucher's disease
A Brautbar1, D Elstein, B Pines
1Gaucher Clinic, Shaare Zedek Medical Center, PO Box 3235, Jerusalem 91031, Israel. gaucher@szmc.org.il.
Some Gaucher's disease patients may have fibromyalgia. Identifying these patients suggests alternative therapies may be more effective than enzyme replacement treatment for their musculoskeletal pain.
Area of Science:
- Medical research
- Genetics and rare diseases
- Pain management
Background:
- Symptomatic Gaucher's disease can present with non-specific musculoskeletal pain unresponsive to enzyme replacement therapy (ERT).
- These symptoms may indicate co-existing fibromyalgia syndrome (FMS).
- Identifying FMS in Gaucher's patients could guide more appropriate therapeutic strategies.
Purpose of the Study:
- To identify adult patients with Gaucher's disease who exhibit criteria for fibromyalgia.
- To explore the potential benefit of fibromyalgia-specific therapies in this patient cohort.
Main Methods:
- A questionnaire-based survey was administered to adult patients with non-neuronopathic Gaucher's disease (n=109) and healthy controls (n=108).
- Participants completed the Fibromyalgia Impact Questionnaire.
- Sensitivity was assessed at 22 tender points using a dolorimeter.
Main Results:
- Six Gaucher's disease patients met the fibromyalgia criteria, while no controls did.
- Fibromyalgia patients had a significantly higher incidence of co-morbidities compared to other Gaucher's patients (p=0.014).
- Among the six, four with fibromyalgia had bone involvement and were on ERT; two were untreated.
Conclusions:
- The presence of fibromyalgia in Gaucher's disease may stem from various causes or be an independent predisposition.
- Distinguishing the exact etiology remains unclear.
- If FMS is the primary cause of symptoms, ERT may be an inappropriate and costly treatment.
More Related Videos
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
06:02Experimental Approaches for Biochemical Analysis of Glial Fibrillary Acidic Protein and Its Disease-associated Variants
Published on: November 28, 2025
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Lysosomal Hydrolases
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Myasthenia Gravis ll: Pathophysiology
Chronic Pancreatitis II: Pathophysiology